Concepedia
Statistics
Publications
22
Citations
2.4K
H-Index
18
Active since
2004
Affiliations
Weizmann Institute of Science(Current)
Rockefeller University
Technion – Israel Institute of Technology
Oregon Health & Science University
Tel Aviv University
Rony Dahan is an author at Weizmann Institute of Science specializing in medicine, immunology, and immunotherapy.
Top concepts
MedicineImmunologyImmunotherapyCell BiologyAutoimmunityTumor ImmunityAutoimmune DiseaseCell SignalingImmunomodulationAntibody Engineering
Publications per year
2004–2025
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna‐Maria Georgoudaki, Kajsa E. Prokopec, Vanessa F. Boura et al. · Cell Reports · 2016 · 607 citations · Full text
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon et al. · Immunity · 2017 · 425 citations · Full text
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
Rony Dahan, Emanuela Sega, John Engelhardt et al. · Cancer Cell · 2015 · 389 citations · Full text
Cancer Immunosurveillance, Pd-1/pd-l1 Axis, Immunology +9
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement
Rony Dahan, Bryan C. Barnhart, Fubin Li et al. · Cancer Cell · 2016 · 163 citations · Full text
Immunology, Therapeutic Activity, Immunologic Mechanism +8
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity
David A. Knorr, Rony Dahan, Jeffrey V. Ravetch · Proceedings of the National Academy of Sciences · 2018 · 99 citations · Full text
1–5 of 22